Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27kip1

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Kadowaki, Maiko ^a   Mizuno, Shiro ^a   Demura, Yoshiki ^a   Ameshima, Shingo ^a   Miyamori, Isamu ^a   Ishizaki, Takeshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CDKN1B PROTEIN, HUMAN; DRUG DERIVATIVE; OXYGEN; PROSTACYCLIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE FIBER;

CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, SMOOTH MUSCLE; OXYGEN; PULMONARY ARTERY; VASODILATOR AGENTS;

EID: 38449101675     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-77     Document Type: Article

References (48)

1. Jeffery TK, Wanstall JC. Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril. Eur J Pharmacol 2001, 416(1-2):123-31.
2. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979, 236(6):H818-27.
3. Rabinovitch M, Konstam MA, Gamble WJ, Papanicolaou N, Aronovitz MJ, Treves S, Reid L. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res 1983, 52(4):432-41.
4. Biernacki W, Flenley DC, Muir AL, MacNee W. Pulmonary hypertension and right ventricular function in patients with COPD. Chest 1988, 94(6):1169-75.
5. Part One MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994, 150(3):833-52.
6. Semmens M, Reid L. Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br J Dis Ches 1974, 68:253-63.
7. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999, 103(5):691-6.
8. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005, 97(9):937-45.
9. Cooper AL, Beasley D. Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. Am J Physiol 1999, 277(4 Pt 2):H1326-37.
10. Frid MG, Aldashev AA, Dempsey EC, Stenmark KR. Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res 1997, 81(6):940-52.
11. Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells. Life Sci 2005, 77(1):28-38.
12. Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible facter-1α promote growth facter-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006, 290:H2528-H2534.
13. Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43(12 Suppl S):56S-61S.
14. Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol 2002, 26(2):194-201.
15. Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest 1999, 103(11):1509-15.
16. Nishio S, Kurumatani H. Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue. Nippon Yakurigaku Zasshi 2001, 117(2):123-30.
17. Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G, . Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002, 39(9):1496-502. Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group.
18. Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral Beraprost sodium, a prostaglandin I2 analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Circulation 2000, 102(4):426-31.
19. Kainoh M, Maruyama I, Nishio S, Nakadate T. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem Pharmacol 1991, 41(8):1135-40.
20. Hatakeyama M, Weinberg RA. The role of RB in cell cycle control. Prog Cell Cycle Res 1995, 1:9-19.
21. Fasciano S, Patel RC, Handy I, Patel CV. Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27kip1. J Biol Chem 2005, 280(16):15682-9.
22. Fouty BW, Grimison B, Fagan KA, Le Cras TD, Harral JW, Hoedt-Miller M, Sclafani RA, Rodman DM. p27kip1 is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2001, 25(5):652-8.
23. Yu L, Quinn DA, Garg HG, Hales CA. Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 2006, 345(4):1565-72.
24. Ii M, Hoshiga M, Fukui R, Negoro N, Nakakoji T, Nishiguchi F, Kohbayashi E, Ishihara T, Hanafusa T. Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27kip1. Cardiovasc Res 2001, 52(3):500-8.
25. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001, 276(11):7919-26.
26. Graff P, Amellem O, Seim J, Stokke T, Pettersen EO. The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res 2005, 25(3B):2259-67.
27. Wang G, Reisdorph R, Clark RE, Miskimins R, Lindahl R, Miskimins WK. Cyclin dependent kinase inhibitor p27kip1 is upregulated by hypoxia via an ARNT dependent pathway. J Cell Biochem 2003, 90(3):548-60.
28. Mizuno S, Kadowaki M, Demura Y, Ameshima S, Miyamori I, Ishizaki T. p42/44 Mitogen-activated protein kinase regulated by p53 and nitric oxide in human pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 2004, 31(2):184-92.
29. Fukuchi K, Tomoyasu S, Watanabe H, Tsuruoka N, Gomi K. G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells. Biochim Biophys Acta 1997, 1357(3):297-305.
30. Cogo A, Napolitano G, Michoud MC, Barbon DR, Ward M, Martin JG. Effects of hypoxia on rat airway smooth muscle cell proliferation. J Appl Physiol 2003, 94(4):1403-9.
31. Krick S, Hanze J, Eul B, Savai R, Seay U, Grimminger F, Lohmeyer J, Klepetko W, Seeger W, Rose F. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005, 19(7):857-9.
32. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000, 58(6):2351-66.
33. Sahai A, Mei C, Pattison TA, Tannen RL. Chronic hypoxia induces proliferation of cultured mesangial cells: role of calcium and protein kinase C. Am J Physiol 1997, 273(6 Pt 2):F954-60.
34. Eto I. Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells. Cancer Cell Int 2006, 6:20.
35. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997, 3(2):231-4.
36. Philipp-Staheli J, Kim KH, Liggitt D, Gurley KE, Longton G, Kemp CJ. Distinct roles for p53, p27kip1, and p21Cip1 during tumor development. Oncogene 2004, 23(4):905-13.
37. Servant MJ, Coulombe P, Turgeon B, Meloche S. Differential regulation of p27kip1 expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 2000, 148(3):543-56.
38. Marra DE, Simoncini T, Liao JK. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21Waf1 and p27kip1. Circulation 2000, 102(17):2124-30.
39. Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, Uehara Y. Induction of p27kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 1997, 15(6):629-37.
40. Dong Y, Aronsson M, Gustafsson JA, Okret S. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 1989, 264(23):13679-83.
41. Jungmann RA, Kelley DC, Miles MF, Milkowski DM. Cyclic AMP regulation of lactate dehydrogenase. Isoproterenol and N6,O2-dibutyryl cyclic amp increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells. J Biol Chem 1983, 258(8):5312-8.
42. Sakaue M, Hoffman BB. cAMP regulates transcription of the alpha 2A adrenergic receptor gene in HT-29 cells. J Biol Chem 1991, 266(9):5743-9.
43. Sakakibara K, Kubota K, Worku B, Ryer EJ, Miller JP, Koff A, Kent KC, Liu B. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem 2005, 280(27):25470-7.
44. Vidal A, Millard SS, Miller JP, Koff A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem 2002, 277(19):16433-40.
45. Dong JM, Leung T, Manser E, Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem 1998, 273(35):22554-62.
46. Laufs U, Marra D, Node K, Liao JK. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27kip1. J Biol Chem 1999, 274(31):21926-31.
47. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004, 287(4):L656-64.
48. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005, 97(2):185-91.